Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion

Health Care CEO Does 180 Zoom Calls In Three Days to Help Take Company Public

A Singular View of COVID-19

Samsung Biologics Launches S-CHOice Cell Line Expression Technology

Light-Based Chips Speed up Cell-Line Development for GSK

Berkeley Lights flies high with $178M IPO

Berkeley Lights, Inc. Rings the Opening Bell in Celebration of its IPO

As We Wait for a Vaccine, Scientists Work to Scale Up the Best COVID-19 Antibodies to Give New Patients

Get to IND Faster: Accelerated and High-Performance Cell-Line Development

Optofluidics Aids Cell Line Development for Antibody-Based Therapies

Antibody Therapies to Cure Coronavirus Now Under Human Trial Phase

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

The Race Is On to Find the Holy Grail of Covid-19 Antibodies

Antibody Shots Could Give Short-Term Doses of COVID-19 Protection. Will They Arrive before a Vaccine?

The Hope behind Antibody Treatments as a Quick Coronavirus Fix

How to Prevent Another COVID-19? ‘Invest in Infrastructure’

Finding the Best Cells for Faster Drug Discovery

Apple Founder Zoom-Bombs Meeting To Thank COVID-19 Scientists